M&A Deal Summary

Synteract Acquires Harrison Clinical Research

On March 1, 2013, Synteract acquired life science company Harrison Clinical Research

Acquisition Highlights
  • This is Synteract’s 1st transaction in the Life Science sector.
  • This is Synteract’s 1st transaction in Germany.

M&A Deal Summary

Date 2013-03-01
Target Harrison Clinical Research
Sector Life Science
Buyer(s) Synteract
Deal Type Add-on Acquisition

Target

Harrison Clinical Research

Munich, Germany
Harrison Clinical Research GmbH is a provider of contract clinical research services for clinical research projects in Germany.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Synteract

Carlsbad, California, United States

Category Company
Founded 1995
Sector Life Science
DESCRIPTION

Synteract, Inc. is an operator of a full-service international contract research organization (CRO) focused on Phase I?IV clinical trials for emerging to mid-sized biopharma clients in the U.S., Europe, and Asia. Synteract was founded in 1995 and is based in Carlsbad, California.


DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Germany M&A 1 of 1
Year: 2013 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-15 KinderPharm

Exton, Pennsylvania, United States

KinderPharm LLC is a clinical stage, specialty pharmaceutical company focusing exclusively on pediatric drug development providing expert and focused resources. KinderPharm LLC was founded in 2014 and is based in Exton, Pennsylvania.

Buy -